Cargando…

High expression of EGFR predicts poor survival in patients with resected T3 stage gastric adenocarcinoma and promotes cancer cell survival

Epidermal growth factor receptor (EGFR) is an essential regulator and biomarker of several types of cancer. However, the association between its expression and prognosis in patients with resected T3 stage gastric adenocarcinoma (RT3-GA) remains to be determined. In total, 683 patients with resectabl...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wang, Daiyong, Wang, Bing, Wang, Ruohan, Zhang, Zaizhong, Lin, Youdong, Huang, Guoliang, Lin, Songbin, Jiang, Yifan, Wang, Wenyuan, Wang, Lie, Huang, Qiaojia
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	D.A. Spandidos 2017
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5431275/ https://www.ncbi.nlm.nih.gov/pubmed/28521408 http://dx.doi.org/10.3892/ol.2017.5827

Ejemplares similares

Involvement of SLC39A6 in gastric adenocarcinoma and correlation of the SLC39A6 polymorphism rs1050631 with clinical outcomes after resection
por: Gao, Jian, et al.
Publicado: (2019)

Evaluation of the expression and clinical value of lncRNA AC010761.9 in human gastric adenocarcinoma
por: Wang, Zhihua, et al.
Publicado: (2018)

EGFR, but not COX-2, protein in resected pancreatic ductal adenocarcinoma is associated with poor survival
por: Fagman, Johan Bourghardt, et al.
Publicado: (2019)

Circular RNAs expression profiles in human gastric cancer
por: Dang, Yuan, et al.
Publicado: (2017)

Expression and clinical significance of long non-coding RNA HNF1A-AS1 in human gastric cancer
por: Dang, Yuan, et al.
Publicado: (2015)

CXCR4 Expression Predicts Early Liver Recurrence and Poor Survival After Resection of Pancreatic Adenocarcinoma
por: Liao, Wei-Chih, et al.
Publicado: (2012)

IL-1β-induced activation of p38 promotes metastasis in gastric adenocarcinoma via upregulation of AP-1/c-fos, MMP2 and MMP9
por: Huang, Qiaojia, et al.
Publicado: (2014)

Coexpression of EGFR and CXCR4 Predicts Poor Prognosis in Resected Pancreatic Ductal Adenocarcinoma
por: Wu, Huanwen, et al.
Publicado: (2015)

Improved survival in patients with unresectable stage III EGFR ‐mutant adenocarcinoma with upfront EGFR‐tyrosine kinase inhibitors
por: Wang, Sheng‐Yuan, et al.
Publicado: (2021)

Glutathione peroxidase 4 expression predicts poor overall survival in patients with resected lung adenocarcinoma
por: Liu, Chao-Yu, et al.
Publicado: (2022)

Decreased HLF Expression Predicts Poor Survival in Lung Adenocarcinoma
por: Wang, Zaiyan, et al.
Publicado: (2021)

CDCA2 promotes lung adenocarcinoma cell proliferation and predicts poor survival in lung adenocarcinoma patients
por: Shi, Run, et al.
Publicado: (2017)

High expression of CXCR4 may predict poor survival in resected pancreatic adenocarcinoma
por: Maréchal, R, et al.
Publicado: (2009)

High expression of CXCR4 may predict poor survival in resected pancreatic adenocarcinoma
por: Maréchal, R, et al.
Publicado: (2010)

Rectal Cancer in West China: Younger Onset, Poor Survival, and Poor Compliance
por: Fang, Chao, et al.
Publicado: (2021)

High expression of PIMREG predicts poor survival outcomes and is correlated with immune infiltrates in lung adenocarcinoma
por: Jiang, Feng, et al.
Publicado: (2021)

Real-World Survival Outcomes Based on EGFR Mutation Status in Chinese Patients With Lung Adenocarcinoma After Complete Resection: Results From the ICAN Study
por: Yang, Xue-Ning, et al.
Publicado: (2021)

Predictive Model for Overall Survival and Cancer-Specific Survival in Patients with Esophageal Adenocarcinoma
por: Huang, He, et al.
Publicado: (2021)

Outcomes of salvage lung resections in advanced EGFR ‐mutant lung adenocarcinomas under EGFR TKIs
por: Chen, Ying‐Yuan, et al.
Publicado: (2021)

Atypical Mucin Expression Predicts Worse Overall Survival in Resectable Pancreatic Ductal Adenocarcinoma
por: Qian, Yunzhen, et al.
Publicado: (2022)

Inflammatory Ratios as Survival Prognostic Factors in Resectable Gastric Adenocarcinoma
por: Nechita, Vlad-Ionuţ, et al.
Publicado: (2023)

Polypeptide N-acetylgalactosaminyltransferase-6 expression independently predicts poor overall survival in patients with lung adenocarcinoma after curative resection
por: Li, Zhi, et al.
Publicado: (2016)

Lower Expression of TWEAK is Associated with Poor Survival and Dysregulate TIICs in Lung Adenocarcinoma
por: He, Zhengxi, et al.
Publicado: (2022)

LncRNA AFAP1-AS1 Modulates the Proliferation and Invasion of Gastric Cancer Cells by Regulating AFAP1 via miR-205-5p
por: Dang, Yuan, et al.
Publicado: (2021)

Computerized tumor-infiltrating lymphocytes density score predicts survival of patients with resectable lung adenocarcinoma
por: Pan, Xipeng, et al.
Publicado: (2022)

Upregulation of ADAM12 Is Associated With a Poor Survival and Immune Cell Infiltration in Colon Adenocarcinoma
por: Huang, Zigao, et al.
Publicado: (2021)

The clinicopathological and molecular characteristics of resected EGFR‐mutant lung adenocarcinoma
por: Zhou, Wensheng, et al.
Publicado: (2022)

High expression of C-C chemokine receptor 2 associates with poor overall survival in gastric cancer patients after surgical resection
por: Li, Ruochen, et al.
Publicado: (2016)

Survival-associated factors of first-line EGFR-tyrosine kinase inhibitor responders and non-responders in lung adenocarcinoma patients with common EGFR mutations
por: Hung, Ming-Szu, et al.
Publicado: (2018)

Acid sphingomyelinase expression is associated with survival in resectable pancreatic ductal adenocarcinoma
por: Wilson, Gregory C., et al.
Publicado: (2023)

Primary Tumor Resection Improves Survival for EGFR-TKI-Treated Patients With Occult M1a Lung Adenocarcinoma
por: Fu, Fangqiu, et al.
Publicado: (2021)

Association of Preoperative Chemosensitivity With Postoperative Survival in Patients With Resected Gastric Adenocarcinoma
por: Deng, Lei, et al.
Publicado: (2021)

Survival after curative resection for stage I colorectal mucinous adenocarcinoma
por: Huang, Liang, et al.
Publicado: (2022)

Association of EGFR Tyrosine Kinase Inhibitor Treatment With Progression-Free Survival Among Taiwanese Patients With Advanced Lung Adenocarcinoma and EGFR Mutation
por: Chen, Po-Yen, et al.
Publicado: (2021)

Enah overexpression is correlated with poor survival and aggressive phenotype in gastric cancer
por: Chen, Di, et al.
Publicado: (2018)

Incorporating radiomic feature of pretreatment (18)F-FDG PET improves survival stratification in patients with EGFR-mutated lung adenocarcinoma
por: Chen, Yu-Hung, et al.
Publicado: (2020)

Clinicopathological predictors of survival in resected primary lung adenocarcinoma
por: Jhala, Hiral, et al.
Publicado: (2022)

AGR2 is associated with gastric cancer progression and poor survival
por: ZHANG, JUN, et al.
Publicado: (2016)

Downregulated SPINK4 is associated with poor survival in colorectal cancer
por: Wang, Xiaojie, et al.
Publicado: (2019)

Expression of Tiam1 predicts lymph node metastasis and poor survival of lung adenocarcinoma patients
por: Liu, Shuguang, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_m7imlshmd6kp6nta07l797oo4r